Malignant mesothelioma is a unusual and aggressive growth where no helpful treatment exists even with the finding of quite a few likely molecular targets. The final stages of MPM diagnosis and the long latency that connects exposures and diagnosis have made it hard to comprehensively learn what risk factors do and the resulting molecular effects.
A [...]